Whether or not you agree with patent protection for Agrobacterium-mediated transformation technology or for other basic platform technologies, “the times, they are a-changing”. In the United States, patents are awarded for many types of biotechnology inventions, including nucleic acid sequences, bacterium containing a vector construct, transgenic plants and methods of making transgenic plants. Both companies and non-profit institutes are affected by such patents. Here, some of the impacts of patents are discussed followed by a mini-primer on key points about patents and patent documents. In the final section, we present a patent landscape of Agrobacterium-mediated transformation of plants and discuss a number of key patents impacting research and development.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
6 References
AUTM, Association of University Technology Managers (2005) AUTM U.S. licensing survey: FY 2004. http://www.autm.org/surveys
Broothaerts W, Mitchell HJ, Weir B, Kalnes S, Smith, LMA, Yang W, Mayer J, Roa-Rodríguez C, Jefferson RA (2005) Gene transfer to plants by diverse species of bacteria. Nature 433: 629-633
CIPR, Commission on Intellectual Property Rights (2002) Implementation of the TRIPS agreement by developing countries. Study paper 7 of the report of the commission on intellectual property rights. http://www.iprcommission.org
Dam K (1999) “Intellectual Property and the Academic Enterprise”, Chicago Eco-nomics Working Paper No. 68 (http://www.ssrn.com, abstract id=1665420)
Epstein RA, Kuhlik B (2004) Is there a Biomedical Anticommons? Regulation 27: 54-58, Available at SSRN:http://ssrn.com/abstract=568401
EPO, European Patent Office (2003) Usage profiles of patent information among current and potential users. http://www.european-patent-office.org/news/info/ survey2003/index.php
Farrand SK, vanBerkum PB, Oger P (2003) Agrobacterium is a definable genus of the family Rhizobiaceae. Int J Syst Evol Microbiol 53: 1681-1687
Feldman M, Colaianni A, Liu K (2005) Commercializing Cohen-Boyer 1980-1997. DRUID Working Paper No. 05-21, http://www.druid.dk Florida Prepaid Postsecondary Education Expense Board v. College Savings Bank et al. 119 S.Ct. 2199 (1999)
Heller MA, Eisenberg RS (1998) Can Patents Deter Innovation? The Anticom-mons in Biomedical Research. Science 280 (5364): 698-701
Hill-Rom Co., Inc. v. Kinetic Concepts, Inc., 209 F.3d 1337 (Fed. Cir. 2000) H.R. Rep. No., 960, 101st Cong., 2d Sess, 1990
Jones PBC (2005) Patent challenges to agbiotech technologies in 2004. ISB News Report February 2005
Lichtman DG (2006) Patent Holdouts and the Standard-Setting Process. U Chi-cago Law and Economics, Olin Working Paper No. 292 Available at SSRN: http://ssrn.com/abstract=902646
Lichtman D, Baker S, Kraus K (2000) “Strategic disclosure in the patent system”, U Chicago Law & Economics, Olin Working Paper No. 107, (http://www. ssrn.com, abstract id=243414) Madey v. Duke University, 307 F.3d 1351, (Fed. Cir. 2002)
Meeks RL (2005) President’s FY 2006 budget requests level R&D funding. NSF 05-322 October 2005
Mireles MS (2004) An examination of patents, licensing, research tools, and the tragedy of the anticommons in biotechnology innovation. U of Mich J of Law Reform 38: 141-235
Monsanto (2005) Bayer CropScience, Max-Planck Society, Monsanto Company resolve Agrobacterium patent dispute. Press release4 February2005, http://www.monsanto.com
National Institutes of Health, Office of Budget, http://officeofbudget.od.nih.gov
NSF (2005) National Science Foundation, Division of Science Resources Statis-tics http://www.nsf.gov/statistics.
NSF SRS (2004) National Science Foundation, Division of Science Resources Statistics, Federal R&D Funding by Budget Function: Fiscal Years 2003-05, NSF 05-303, Project Officer, Ronald L. Meeks (Arlington, VA 2004).
Nottenburg C, Pardey PG, Wright BD (2002) Accessing other peoples’ technology for non-profit research. Aust J of Agric and Res Econ 48: 389-416
Pitcairn v. United States, 547 F.2d 1106 (Ct. Cl. 1976), cert. denied, 434 U.S. 1051 (1978)
Plant Genetic Systems N.V. v. DeKalb Genetics Corp. 315 F.3d 1335 (Fed. Cir. 2003) Press E, Washburn J (2000) The kept university. The Atl Monthly 285: 39-54
Roa-Rodríguez C, Nottenburg C (2003) Agrobacterium-mediated transformation of plants, CAMBIA Patent Lens (http://www.patentlens.net)
Roche Products v. Bolar Pharmaceutical Co., 733 F.2d 858 (Fed. Cir. 1984), cert. denied, 469 U.S. 856 (1984)
Stern S, Murray FE (2005) Do Formal Intellectual Property Rights Hinder the Free Flow of Scientific Knowledge? An Empirical Test of the Anti-Commons Hypothesis. NBER Working Paper No. W11465. Available at SSRN:http://sssrn.com/abstract=755701
Wolf S, Zilberman D (2001) Institutional Innovation in Agriculture. Natural Res Mgmt and Policy 19: 1-394 Kluwer Academic Publishers
Young JM, Keykendall LD, Martinez-Romero E, Kerr A, Sawada H (2001) A re-vision of Rhizobium Frank 1889, with an amended description of the genus, and the inclusion of all species of Agrobacterium Conn 1942 and Allorhizo-bium undicola de Lajudie et al. 1998 as new combinations: Rhizobium radio-bacter, R. rhizogenes, R. rubi, R. undicola and R. vitis. Int J Syst Evol Microbiol 51: 89-103
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Nottenburg, C., Rodríguez, C.R. (2008). Agrobacterium-Mediated Gene Transfer: A Lawyer’s Perspective. In: Tzfira, T., Citovsky, V. (eds) Agrobacterium: From Biology to Biotechnology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-72290-0_20
Download citation
DOI: https://doi.org/10.1007/978-0-387-72290-0_20
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-72289-4
Online ISBN: 978-0-387-72290-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)